GlassScriptPhysician profile
Khalil Snowber
NPI 1225487481
$6,105.50
in general payments reported to CMS, 2019-2025
38 companies · $1,360 in 2025
The $1,360 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $603 · 2020: $26.49 · 2021: $98.35 · 2022: $794 · 2023: $1,534 · 2024: $1,690 · 2025: $1,360.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,584.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $728.71 | 2019-2025 | Breztri, Airsupra, Farxiga |
| Abbvie INC. | $712.95 | 2019-2025 | Ubrelvy, Linzess, Viberzi |
| Lilly USA, LLC | $530.99 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Novo Nordisk INC | $518.64 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Nestle Healthcare Nutrition INC. | $372.13 | 2021-2023 | |
| Aimmune Therapeutics, INC. | $371.66 | 2024 | |
| Amgen INC. | $292.60 | 2022-2025 | Evenity, Repatha, Prolia |
| Novartis Pharmaceuticals Corporation | $238.72 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $227.69 | 2019-2024 | Xarelto |
| Pfizer INC. | $203.89 | 2019-2025 | |
| Exact Sciences Corporation | $191.14 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $163.48 | 2019-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $137.80 | 2022-2025 | |
| Phathom Pharmaceuticals, INC. | $134.64 | 2024-2025 | Voquezna |
| Radius Health, INC. | $132.59 | 2024-2025 | Tymlos |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khalil Snowber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.